Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
NCT ID: NCT02617888
Last Updated: 2017-07-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
228 participants
INTERVENTIONAL
2011-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To investigate the effects of cardiac imaging radiation on the induction of DNA double-strand breaks by enumerating gamma-H2AX foci in blood lymphocytes and plucked hair follicle cells.
2. To estimate whether the use of breast shields in cardiac computed tomographic angiography (CCTA) limits the effective radiation exposure of breast tissue.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hybrid SPECT/CTCA for the Assessment of the Presence and Hemodynamic Significance of CAD in Asymptomatic Patients.
NCT01239446
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
NCT03575910
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients
NCT00716898
Assessment of Myocardial Viability Using Multidetector Computed Tomography
NCT00285064
Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction
NCT05536960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary objective is to investigate whether the use of in-plane breast shielding in female patients undergoing CT angiography (CCTA) limits the radiation exposure of breast tissue and subsequent DNA damage in blood lymphocytes and hair follicle cells.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CCTA Breast Shields
Within female subset, randomization to wearing bismuth breast shield.
CCTA ~ BREAST SHIELDS
Breast shield placement (randomized) among women.
CCTA No Breast Shields
Within female subset, randomization to wearing no bismuth breast shield (standard of care).
No interventions assigned to this group
Observational Arm
Non-females undergoing CTA and subjects undergoing cardiac catheterization and nuclear medicine testing.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CCTA ~ BREAST SHIELDS
Breast shield placement (randomized) among women.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred for cardiac computed tomography angiography (CCTA), myocardial perfusion scintigraphy (MPS), or diagnostic invasive coronary angiography (ICA).
Exclusion Criteria
* History (present or past) of leukemia or lymphoma.
* History of radiation therapy
* X-ray examination or scintigraphy within the last 72 hours.
* History of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
* Patients undergoing percutaneous coronary intervention at completion of diagnostic left heart catheterization
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Walter Reed National Military Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Todd C. Villines
Director of Cardiovascular Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Todd C Villines, MD
Role: PRINCIPAL_INVESTIGATOR
WRNMMC
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
362425
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.